Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My Fidelity acct. Not show price. Show N/A.
Fidelity show Regen new sticker RGBP
I got filled 500K @.0028 today
I am sure I will get fill this week at 27. If news not come out this week.
I try buy 500K shares today @ 27 not fill yet. Hopefully fill this week b4 news come out.
Cash Is King _ Merck sign with Biomatrix Scientific Group (BMSN) a progress report on therapeutic cancer vaccine drug candidate dCelVax predict Sierra world equity
BMSN to receive upfront payment of $16 millions and 3% royalty payment from Merck (MRK) for any FDA successfully cleared pipeline drugs predict Sierra World Equity Review
I have another 50 yrs to live. I can pass to my grandson. PATIENCE is the key. I been waiing this stock 2 yrs already time fly, don't think. so 48 yrs to go BMSN.
Warren Buffett said "Power of patience" If you invest in 1919 Cola-Cola with $40 turn into today $10 millions.
If same thing with BMSN if you leave for next 50 yrs become multi-millionaire.
PATIENCE IS THE KEY
GO BMSN
stockcaser64
seem like you don't stem cell. Why don't you go fuel cell. I give you my pick of day GEIG today gain 140%
Just added 400k today @ .0032
Hey onfire
you didn't add my sis 1 mil and phillip631 1/4 MIL, too little you don't wanna add in.
my sis got 1 mil today. not much
add my bro.+ friend 11mil
12mil avg. @.0022
Be patient time not come yet, few more weeks will be.
I been here since 2012. I have been adding at bottom Nov. & Dec.
I have been looking other company filing prospectus 424b3 around 60 days, they have a sticker. We filing prospectus 424b3 on May 19.I hope BMSN same thing.
Regen filing 10Q today my guess should get 2 wks from today. If we get sticker earlier is a plus. It's tough from now to next 2 week no volume and you should hear a lot negative about koos.
we should get sticker next 2 weeks, around May 19.
ABC headline news said: Stem Cells Shine Where Other Transplant Drugs Fail
http://abcnews.go.com/Health/video/estrogen-therapy-brings-benefits-risks-15862073
We should see prs around May 19.
I hang on too long here already since Oct.2012, never sell single share. I have been adding a lots at bottom .0012-.0015. I will more end of May, if prs not come out.
prospectus 424b3 was filed on Mar.19. 60 days from filing.
Next month will be explode.
I would say in May 19 to be explode.
end of May if no news. I'm adding more shares. News come in May it's good enough for me.
News not come out end of May. I will buy your shares.
I agree you Bare1, This thing will explode if not this year definite next year. I will wait. I have been waited almost 2 yrs already another year or 2 for me is nothing. Just part of my investment I believe BMSN will be BIGGGGG.
This Thursday exactly 30 days submitted 424B3 Prospectus. Hopefully Koos drop some news this week b4 Good Friday. Make everyone have a nice long holiday weekend.
30-60 days after March 19
Gmayes, why you wasting your time posting. Don't you have better thing do? You don't this stock GEEET OUT.
Thursday is KOOS day
Everyone think news may come out today had been 30 days from last pr.
Friday`s new trade plan is simple: Fly in fast, glean some profits, swoop out and have a safe landing! Those who have been with us awhile already are aware the exceptional great results we`ve experienced with Sub-Penny plays.
For many reasons these are the darlings of Wall Street as they make major moves in short periods of time. High percentage returns can be garnered in just a few short hours, or days. Our long time subscribers have seen several alerts trend up throughout the day and peak at 200, 300, and even 400% returns! With all the above in mind, we`ve been fine tuning our super sensitive scanner to find a Sub-Penny with momentum and a chart to match. To say I`m very confident having found just that is quite the understatement!Our Momo Sub-Penny Pick: BMSN ~ Bio-Matrix Scientific Group ~
Hurry – Begin your research now on BMSN – Bio-Matrix Scientific sitting at just .005, on the upswing with a breakout potentially looming as a chart play for Friday. Remember, history has a way of repeating itself often.BMSN: Is this the Next Sub-Penny to Soar…
Perhaps even go Viral – It`s Chart sure is acting like it!Technical Analysis:
BMSN – This Momo Sub-Penny chart even makes the most conservative traders itching to get involved! See Chart Here: Sub-Penny Momentum – Breakout Looms BMSN and it`s chart goes back to the beginning of 2013 and displays the pure power potential of Sub-Penny plays and gives solid credence to why our members ask for them. The stock commenced a meteoric rise from $0.001 all the way to $0.016 – a 1500% return! To put this in perspective, if your money was earning a generous 1% in the bank, it would take roughly 1500 years for it to generate a 1500% return.
Only in the case of BMSN, this happened in less than 2 months…
Sheer ultra-power potential! After the peak and subsequent pullback, a base was formed around the $0.009 – $0.01 level and it consolidated, spiked, consolidated and spiked. Looks like a healthy trading pattern, right Well, it was….until it wasn`t any longer.
We can see a substantial retracement after the $0.016 Triple Top, and the stock appears to have bottomed between the $0.004 and $0.0055 levels. Being that BMSN has traded in that range for the last 8 trading sessions and has produced 2 bottoming tails during that time, the chart provides empirical evidence which suggests a bottom is in place.
Now – onto the flight plan: How to trade this Well, the old school of thought says to pick your entries. Since we`re showing solid support within that range one could simply pick your entry point. The clear-cut breakout is above $0.006 which takes it above the range.
Our first target would naturally be the 50 day Simple Moving Average of $0.008. This is a 25% move off the breakout and potential 40% move for those picking their spots. Being that this area also converges with the 20 day Moving Average, it shows us ample overhead resistance so we have to respect that area and look for profit taking in that region.
The 10 day MA of $0.005 provides a safe area for stop loss as there is no support below that region. This is a risk/reward trade clearly in our favor. Keep a close eye out for early momentum by traders being the key.About Bio-Matrix Scientific:
BMSN: Bio-Matrix Scientific Group – focuses on the development of regenerative medicine therapies and tools to treat lung, heart, circulatory system, and other internal organs. It also focuses on developing translational medicine platforms for the commercialization of stem cell therapies for the treatment of diabetes, chronic obstructive pulmonary disease, heart related illness, and circulatory issues.
The company, through its subsidiary, Entest BioMedical, Inc., focuses on developing and commercializing therapies, medical devices, and medical testing procedures for the veterinary market, as well as on acquiring and operating veterinary clinics.
Visit the company`s official website here and see for yourself:
http://clicks.aweber.com/y/ct/l=4k3kt&mLsNHmgE0976pl&b=MOR36mn8VNqrr12Mfo4MjA BMSN: Is Fast-Forwarding Stem Cell Medicine BMSN has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy “signal” and spin out technologies.
BMSN believes there is a major inefficiency in the development of stem cell therapies: companies are set up, large costs are spent on infrastructure development, then when the product fails everything goes to waste. Their approach is to establish an infrastructure that can be used for multiple therapeutic products.
BMSN: Running of the Press…Making Headlines BMSN recently announced issuance of IND number 15376 for its proposed Phase I/II clinical trial evaluating use of its stem cell product, HemaXellerate, for treatment of aplastic anemia.As part of the clinical trial approval process, the FDA will issue comments on the proposed trial which must be addressed to the FDA`s satisfaction before patient dosing is initiated. The clinical trial will treat ten patients with aplastic anemia that have not responded to conventional therapy and lack a bone marrow donor.HemaXellerate is a patient-specific composition of cells that have previously been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. If the clinical trial is successful, the company plans to expand use of HemaXellerate(TM) to other conditions associated with bone marrow dysfunction, with the overall goal of entering the hematopoietic growth factor market. This market is substantial in size and currently includes drugs such as Neupogen, Neulasta, Leukine and Revolade.
*** Did You Know — BMSN entered into a Letter of Intent to purchase patented intellectual property covering a novel means of treating breast cancer by augmenting the immune system using a “gene silencing” approach. The technology has been published in peer-reviewed journals by Professor Min, which documents its capacity of reducing tumors in melanoma (Zheng et al. J Immunol.
Read more at http://www2.thestockmarketwatch.com/newsletters/2013/04/05/bmsn-is-our-new-special-sub-penny-pick-perhaps-a-soaring-viral-friday/#VPHqUrFTyPOzdCFM.99
[b]10 Best Medical Stocks To Buy For 2014: Bio-Matrix Scientific Group Inc (BMSN)
Bio-Matrix Scientific Group, Inc., incorporated on October 6, 1998, is a development stage company. The Company, through its wholly-owned subsidiary Regen BioPharma ,Inc., is engaged in the development of regenerative medical applications which it focuses to license from other entities up to the point of completion of Phase I and or Phase II clinical trials after which it would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.
The Company has begun development of HemaXellerate, a cellular drug designed to heal damaged bone marrow. HemaXellerate I (TM) is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies.
Advisors’ Opinion:
•[By Bryan Murphy]
If you’re a small cap enthusiast looking for some budding ideas, you may not need to look any further than China GengSheng Minerals, Inc. (NYSEMKT:CHGS), Bio Matrix Scientific Group Inc. (OTCMKTS:BMSN), and MER Telemanagement Solutions Ltd. (NASDAQ:MTSL). All three have either pushed themselves to the brink of a breakout, if they haven’t started one already. Here’s a closer technical look at MTSL, BMSN, and CHGS, and what it’s going to take to get them going if they’re not going already.
•[By Peter Graham]
A quick look at Amanasu Techno Holdings Corp reveals no revenues; net losses of $5k (most recent reported quarter), $18k and $3k and net income of $12k for the past four reported quarters; and $6k in cash to cover $361k in current liabilities at the end of September meaning the company is a long way off from its capital raising goals.
Bio Matrix Scientific Group Inc (OTCMKTS: BMSN) Plans a Special Dividend
Small cap Bio Matrix Scientific Group is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. On Friday, Bio Matrix Scientific Group surged 42.31% to $0.0074 for a market cap of $21.84 million plus BMSN is down 32.11% over the past year and down 95.9% over the past five years according to Google Finance.
NEWS.. BMSN.. Develop Commercializes medical devices
Las Vegas, NV -- (SBWIRE) -- 01/16/2014 -- Bio Matrix Scientific Group Inc (OTCMKTS:BMSN) designs, develops and commercializes medical devices. Some of these devices are disposable that help extract stem cells and transfer tissues. Bio Matrix also produces and sells therapies, devices and testing processes.
Bio-Matrix Scientific Group, Inc., operates via its subsidiary, Regen BioPharma, Inc. The company develops regenerative medical applications and offers a cellular drug HemaXellerate. This drug heals damaged bone marrow.
Bio-Matrix ’s drug HemaXellerate is tailored composition of cells for patients. BMSN is based in California and conducts research on animals.
To find out what OTCMAGIC projects for Bio Matrix Scientific Group Inc for both short term and long term please click here: BMSN
http://www.sbwire.com/press-releases/insights-on-bio-matrix-scientific-group-inc-otcmktsbmsn-437181.htm
.004 is bottom. we should have regen ticker and news next week
Friday another blood day. probably Monday Koos release pr is deadline.
Anyone think news coming out today? I don't see Noone talk about news today.
TDA have not show Regen share yet. it's suck
I have 2 accounts Fidelity and td ameritrade. I got Regen shares on Fidelity acct. not on TD AMERITRADE yet.
I guess only fidelity received it.